SMTL ID : 4yti.1

Discovery of VX-509 (Decernotinib): A Potent and Selective Janus kinase (JAK) 3 Inhibitor for the Treatment of Autoimmune Disease

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.52 Å

Oligo State

monomer

Ligands

1 x VJK: (2R)-2-methyl-2-[[2-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]-N-[2,2,2-tris(fluoranyl)ethyl]butanamide(Non-covalent)

VJK.1: 16 residues within 4Å: Chain A: L.19, G.20, V.27, A.44, V.75, E.94, Y.95, L.96, G.99, S.100, R.144, N.145, I.146, L.147, G.157, D.158 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.19, A:V.27, A:V.27, A:A.44, A:L.147, A:L.147 Hydrogen bonds: A:L.19, A:L.96, A:L.96, A:S.100, A:R.144, A:D.158

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Farmer, L.J. et al., Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases. J.Med.Chem. (2015)

Release Date

2015-08-12

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence